Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming

We previously reported results of a phase II trial in which recombinant MAGE-A3 protein was administered with or without adjuvant AS02B to 18 non-small-cell lung cancer (NSCLC) patients after tumor resection. We found that the presence of adjuvant was essential for the development of humoral and cel...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Atanackovic, Djordje, Altorki, Nasser K., Cao, Yanran, Ritter, Erika, Ferrara, Cathy A., Ritter, Gerd, Hoffman, Eric W., Bokemeyer, Carsten, Old, Lloyd J., Gnjatic, Sacha
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2008
Teme:
Biological Sciences
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2234199/
https://ncbi.nlm.nih.gov/pubmed/18216244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0707140104
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items